INTRODUCTION
Atherosclerosis is a leading worldwide cause of morbidity and mortality [1, 2] . The incidence of cardiovascular dis eases (CVDs), including cerebrovascular, peripheral arterial, and coronary artery disease, is increasing and accounts for approximately onefourth of all deaths in World Health Organization member states [3] . More than 17 million people die annually from CVDs, and, by 2030, more than 23 million CVDrelated deaths are expected to occur worldwide. In Japan, the agestandardized fraction of mortality from CVDs is approximately 30%.
The anklebrachial index, pulsewave velocity, flow mediated dilation, and ultrasonic evaluation have been introduced as methods for assessing the structural and functional effects of atherosclerosis [46] . Carotid atherosclerosis, estimated by intimamedia thickness (IMT), is a sensitive surrogate marker for CVD and can now be noninvasively measured by Bmode ultrasonography [7, 8] .
IMT is a marker for systemic subclinical atherosclerosis and a strong predictor of incident myocardial infarction and ischemic stroke [9, 10] . Carotid plaque may be an even more powerful predictor of vascular outcomes than IMT [11, 12] . Maximum carotid plaque thickness (MCPT), widely used for assessing atherosclerotic change, is associated with an increased risk of vascular morbidity [13] . High plasma adiponectin independently predicted death and major adverse cardiovascular events in a large communitybased population [14] . Highsensitivity Creactive protein serum levels were reported to be significantly related to the severity of coronary atherosclerosis [15] . In addition to these markers, serum cystatin C (CysC) has recently been proposed as a more reliable biomarker for atherosclerosis and chronic renal disease. Furthermore, high CysC levels are indicated as a useful marker for identifying an elevated risk of CVD and a higher total mortality among patients assessed as being at low risk by both creatinine (Cr) and estimated glomerular filtration rate (eGFR) values [16, 17] . A previous study revealed that atherosclerotic changes associated with inflammation could be one mechanism by which CysC is associated with CVD [16] . However, the association between CysC and atherosclerotic disorders remains controversial, the cutoff values of CysC for atherosclerosis are unknown, and previous reports on this association as well as the association between CysC and MCPT are limited [1820] . A diagnostic CysC cutoff value has not been determined. In this study, we examined the association between CysC levels and atherosclerotic changes in Japanese subjects.
MATERIALS AND METHODS

Subjects
The present crosssectional study included 133 Japanese subjects who underwent an inpatient medical health checkup at Juntendo University Hospital, Tokyo from October 2010 to January 2013. Among these subjects, five were excluded because of missing laboratory data. Thus, 128 subjects [98 men and 30 women; median age, 70 years (age range, 3987 years)] were included.
The subjects were asked to complete a selfadmi nistered questionnaire about their sociodemographic characteristics, past medical history (diabetes, hyper tension, and dyslipidemia), and lifestyle behaviors (alcohol consumption, current smoking status, and daily exercise activity).
The body weight, height, and waist circumference of the patients were measured, and the bodymass index [BMI (kg/m 2 )] was calculated. Systolic and diastolic blood pressure were measured in a sitting position after a 15min rest using a standard mercury sphygmomanometer. Venous blood samples were collected following overnight fasting. Plasma glucose concentrations, hemoglobin A1c (HbA1c), total cholesterol (TC), highdensity lipoprotein cholesterol (HDLC), triglyceride (TG), Cr, and CysC levels were also measured. Lowdensity lipoprotein cholesterol was estimated using the Friedewald equation [TCHDLC (TG/5)]. For the assessment of visceral fat accumulation, abdominal fat areas were measured from abdominal CT scans taken at the umbilical level while in the supine position and during late expiration, according to the Japanese Guidelines for Obesity Treatment [21] . The following parameters were calculated: eGFR was calculated using the Japanese GFR inference for mula, which was developed by the Japanese Society of Nephrology [22] : eGFR (mL/min per 1.73 m 2 ) = 194 × serum Cr (mg/dL) 1.094 × age (years) 0.287 (× 0.739 if female).
HbA1c was calculated as the National Glycoh emoglobin Standardization Program (NGSP) value (%), which was developed by the Japan Diabetes Society [23] : HbA1c = NGSP (%) × 1.02 + 0.25.
Lifestyle-related diseases were defined using several criteria: (1) diabetes mellitus was defined as an HbA1c level of ≥ 6.5%, a fasting plasma glucose level of ≥ 126 mg/dL, or current antidiabetic therapy [24] ; (2) hypertension was defined by a systolic blood pressure of ≥ 140 mmHg, a diastolic blood pressure of ≥ 90 mmHg, or current antihypertensive therapy [25] ; and (3) dyslipidemia was defined as a fasting TG level of ≥ 150 mg/dL, a lowdensity lipoprotein cholesterol level of ≥ 140 mg/dL, or an HDLC level of < 40 mg/dL [26] . Three unhealthy lifestyle behaviors were evaluated in this study: Drinking alcohol more than once a week, current smoking, and no regular physical activity.
A detailed protocol for measuring carotid artery atherosclerosis has been published [27] . Carotid plaque and IMT were measured using highresolution Bmode ultrasonography to estimate atherosclerosis in the carotid artery. Eight technicians who were trained by a supervisor physician and who were certified in the protocol assessed carotid plaque and the mean IMT of the common carotid artery. A plaque was defined as a maximum IMT of > 1.0 mm. MCPT was measured at the peak plaque prominence in any of the carotid artery segments. Atherosclerosis was defined on the basis of the severity of carotid atherosclerosis by MCPT at a cut off level of 2 mm. As previously reported, an MCPT of ≥ 2 mm is defined as an atherosclerotic change [13] .
Statistical analysis
The results were expressed as medians of the test parameters. The Youden index, a point on the receiver operating characteristic (ROC) curve, was used to determine the diagnostic values of serum CysC levels that were indicative of atherosclerosis.
In a second analysis, the subjects were divided into two groups according to CysC levels above and below the cutoff value. Their demographic characteristics were then compared using the t test for continuous variables and the chisquare test for categorical variables. Multiple logistic regression analysis with adjustments for age and sex was conducted to determine the correlations between an MCPT of ≥ 2 mm and metabolic variables including CysC level. Our study included only 128 subjects, of whom 52 had arteriosclerosis. Because there is a limit to the number of adjusted variables, we combined several metabolic related variables in one item. Variables that were significantly associated with an MCPT of ≥ 2 mm were then investigated with multiple logistic regression analysis.
Statistical test results were considered significant when the P value was < 0.05. All calculations were performed using JMP Pro, version 11 (SAS Institute, Cary, NC, United States). The study protocol was approved by the Human Ethics Committee of Juntendo University. The participants' clinical data were retrospectively retrieved from an institutional database. All of the examinations included in this study were performed as a routine part of the program, and none were aimed at specifically collecting data for the current study. The study protocol was approved by the institutional ethics committee, so it was not necessary to obtain informed consent from the participants. A biostatistician reviewed the study.
RESULTS
The subject characteristics are shown in Table 1 . The median age was 70 years (77% males). Twenty three (18%) subjects smoked, 78 (61%) were alcohol consumers, and 90 (70%) did not exercise regularly. The median visceral fat area was 125.2 cm 2 . Sixtyone (48%) subjects were diagnosed with hypertension, 72 (56%) with dyslipidemia, and 29 (23%) with diabetes mellitus. The ROC analysis conducted to determine the cut-off value of CysC revealed a significantly higher risk of atherosclerosis at 0.73 mg/L (Figure 1) (sensitivity: 82.7%, specificity: 52.6%).
The subjects were then divided into two groups according to the CysC cutoff value (0.73 mg/L). The subjects' characteristics according to the CysC level are shown in Table 2 . The median age of the high CysC group was 72 years (85% males), whereas that of the low CysC group was 61 years (63% males). The CysC levels were significantly correlated with Cr and eGFR values. BMI, visceral fat area, hypertension, diabetes mellitus, and MCPT were significantly higher in the high CysC group than in the low CysC group. Furthermore, the eGFR was significantly lower in the high CysC group. Regarding lifestyle habits, only the exercise level was
DISCUSSION
In this study, multivariate analysis revealed that higher CysC levels were significantly associated with carotid atherosclerosis, as defined by an MCPT of ≥ 2 mm, in middleaged and elderly Japanese subjects. The cut off CysC value (0.73 mg/L) could aid in the diagnosis of atherosclerosis. To our knowledge, this is the first report demonstrating an association between CysC and carotid atherosclerosis as assessed by MCPT. The CysC cut off level potentially has promising clinical value in the diagnosis of atherosclerosis.
Our results revealed a significant association between high CysC levels and an MCPT of ≥ 2 mm. A meta analysis previously revealed that CysC is strongly and independently correlated with the risk of subsequent cardiovascular disease [28] . Although several studies have revealed an association between high CysC levels and atherosclerosis, their results differed from ours be cause of the different targets and indicators used. A previous study, which analyzed 637 Japanese subjects without chronic kidney disease, revealed that CysC was positively correlated with the cardioankle vascular index in women [19] . In a study of 60 Japanese hypertensive patients, serum CysC levels were positively correlated with carotid IMT [29] . In data collected via 64slice CT coronary angiography, a high CysC level was found to be significantly correlated with earlystage coronary atherosclerotic plaques in 405 Japanese patients without established chronic kidney dysfunction [18] . Our results are in agreement with the previous hypothesis that CysC level is a reliable marker for atherosclerosis.
There are several possible explanations for the asso ciation between CysC and atherosclerotic change. First, inflammation may be associated with both CysC and atherosclerosis. The Cardiovascular Health Study [30] , which lower in the high CysC group than in the low CysC group. In addition, sensitivity, specificity, positive predictive value, and negative predictive value as calculated from the data in Table 2 were 83%, 53%, 54% and 82%, respectively.
Next, we compared differences in demographics and clinical variables between subjects with MCPTs of ≥ 2 mm or < 2 mm (Table 3) . Age, visceral fat area, hypertension, diabetes mellitus, Cr, eGFR, and CysC were significantly higher in the MCPT of ≥ 2 mm group than the < 2 mm group. Furthermore, the eGFR was significantly lower in the MCPT of ≥ 2 mm group. The two groups did not differ with regard to lifestyle habits.
The factors associated with an MCPT of ≥ 2 mm are shown in Table 4 . Multivariate analysis, adjusted for age and sex, revealed that high CysC levels were significantly associated with an MCPT of ≥ 2 mm (odds ratio: 2.92; 95%CI: 1.137.99). appropriate devices. Therefore, it is potentially important that atherosclerosis can be evaluated using a blood test, such as for CysC levels. A diagnostic CysC cutoff value has not been previously determined. Our study revealed that the CysC cutoff value of 0.73 mg/L could contribute to the diagnosis of atherosclerosis. Our study had a few limitations. First, the subjects were selected from a single institution, the sample size was small, and > 70% of our subjects were healthy men. Selection bias may have affected the analysis, as the investigated cohort did not accurately represent the Japanese population. Thus, future largescale cohort studies are required. Second, lifestyle habits were evaluated using a selfadministered questionnaire, and the subjects may have stated that they had a healthier lifestyle than they actually did. Further evaluations of lifestyle habits based on a validated questionnaire are analyzed 4637 ambulatory elderly patients, revealed a significant linear association between CysC and C-reactive protein but not Cr or eGFR [31] . It is well known that inflammation plays a role in atherogenesis, atherosclerotic plaque progression, and acute coronary syndrome. Second, CysC plays an important role in maintaining athero sclerotic plaque stability. A previous study [32] analyzed 31 plaques removed by endarterectomy, demonstrating with immunohistochemistry that CysC in human carotid plaques localized with collagen and elastin. An imbalance between cysteine proteases and CysC in arterial wall remodeling occurs in vascular diseases, such as atherosclerosis and abdominal aortic aneurysm [33] . Imaging assessments, such as ultrasound and CT, are often performed for assessing arteriosclerotic vascular disease. However, not all institutions can practice such assessments because of the lack of sonographers or A prospective study is required for determining whether higher CysC levels are associated with the development of atherosclerosisrelated diseases or death.
In conclusion, higher CysC levels were correlated with carotid atherosclerosis as defined by an MCPT of ≥ 2 mm among middleaged and elderly Japanese subjects. Higher CysC levels have a low specificity but a high sensitivity and can therefore help exclude atherosclerosis. The CysC cutoff value of 0.73 mg/L appears to aid in the diagnosis of atherosclerosis. Our data indicate that CysC could be a useful laboratory tool for predicting atherosclerosis during health checkups.
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Atherosclerosis is a leading worldwide cause of morbidity and mortality. Carotid plaque may be a powerful predictor of vascular outcomes. Maximum carotid plaque thickness (MCPT), widely used for assessing atherosclerotic change, is associated with an increased risk of vascular morbidity.
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Serum cystatin C (CysC) has recently been proposed as a reliable biomarker for atherosclerosis and chronic renal disease. However, the association between CysC and atherosclerotic disorders remains controversial, the cut-off values of CysC for atherosclerosis are unknown, and previous reports on this association as well as the association between CysC and MCPT are limited. A diagnostic CysC cut-off value has not been determined.
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Higher CysC levels were associated with an MCPT of ≥ 2 mm. The CysC cutoff value of 0.73 mg/L appears to aid in the diagnosis of atherosclerosis.
Applications
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